It makes rejection, teasing or criticism feel unbearable, often prompting a strong physical reaction. Sufferers describe life with a condition that is only just starting to be understood Jenna ...

No one is excited to deal with social rejection, but people with a certain mental health condition may struggle with this more than others. It’s called rejection sensitivity dysphoria, and Paris ...

One young woman’s mission of being rejected 1,000 times has inspired other social media users to seek out noes. Credit...via Gabriella Carr Supported by By Megan Farokhmanesh Gabriella Carr held up a ...

Early in her career, USA Today best-selling author Emma Grey felt like rejection would break her. Today, she’s made rejection something to reach for. The fear of rejection is evolutionary—we are ...

In this study, investigators evaluated whether a functional C3 gene variant is linked to outcomes after lung transplantation. They focused on the C3R102G polymorphism, which enhances complement ...

Liver transplants often save the lives of seriously ill patients. However, there remains a risk that the body will reject the new organ. Doctors distinguish between acute and chronic rejection. While ...

Century Therapeutics Inc. has announced its first program for type 1 diabetes, CNTY-813. The program comprises induced pluripotent stem cell (iPSC)-derived β islets engineered with the company’s ...

Have you ever felt an overwhelming wave of emotional pain when you thought someone was criticizing or rejecting you? If so, you might have been motivated by rejection sensitivity. Rejection sensitive ...

Getting rejected stings. Whether it’s a pass on a potential date, a declined job application, or a friend who can’t hang out, rejection triggers real emotional pain. 1 For some people, the fear of ...

You have /3 articles left. Sign up for a free account or log in. A “wall of rejection” is often a metaphorical barrier to success, but at the University of ...

The product is expected to be available in early 2026. The Food and Drug Administration (FDA) has approved Qivigy (immune globulin intravenous [IV], human-kthm) 10% solution for the treatment of ...

According to reporting from multiple outlets, Richard Pazdur, head of the Oncology Center of Excellence at CDER, opposed the consensus opinion of CBER staff to approve the drug. Replimune’s stock has ...